IM Cannabis (IMCC) Current Assets (2019 - 2026)

IM Cannabis (IMCC) posted quarterly Current Assets of $11.0 million for Q1 2026, down 32.4% quarter-over-quarter from $16.3 million in Q4 2025.

IM Cannabis (IMCC) Current Assets (2019 - 2026) Analysis & Trends

IM Cannabis' Current Assets history runs 8 years deep, the most recent figure standing at $11.0 million for Q1 2026.

In Q1 2026, Current Assets changed N/A year-over-year to $11.0 million; the TTM figure through Mar 2026 stood at $11.0 million (changed N/A YoY), while the FY2025 annual figure was $16.3 million, down 4.44% from the prior year.
Current Assets for Q1 2026 stood at $11.0 million, down from $16.3 million in the prior quarter.
The five-year high for Current Assets was $74.0 million in Q3 2022, with the low at $11.0 million in Q1 2026.
The 5-year median for Current Assets is $20.7 million (2023), against an average of $27.0 million.
The sharpest annual moves came in 2022 and 2023: Current Assets surged 49.95% in 2022, then sank 71.44% in 2023.
IM Cannabis' Current Assets stood at $24.1 million in 2022, then fell by 25.95% to $17.8 million in 2023, then retreated by 6.16% to $16.7 million in 2024, then fell by 2.5% to $16.3 million in 2025, then plunged by 32.4% to $11.0 million in 2026.
Business Quant data shows IMCC's Current Assets at $11.0 million in Q1 2026, $16.3 million in Q4 2025, and $23.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Assets (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	5.76 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	13.76 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	6.36 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	19.76 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	3.48 Bn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	10.06 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	1.64 Bn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	3.80 Bn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	3.22 Bn
10	IM Cannabis	554,496.00	-614,474.17	1.09 Mn	11.79 Mn

Download Data